arrow
P

Pablo García-Manau

vall d’hebron institut de recerca
H指数:13
被引数:837

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prediction of preterm pre-eclampsia and preterm small-for-gestational-age at 24–28 weeks of gestation using ultrasound and biochemical markers in high-risk pregnancies treated with aspirin: A secondary analysis of the StopPRE trial

使用超声和生物化学标志物预测接受阿司匹林治疗的高危妊娠在24~28周时的早产子痫前期和早产胎儿宫内生长受限:StopPRE试验的二次分析

2026-09-300
PRE
Protocol for the external validation of machine learning models for risk prediction in early-onset preeclampsia: a multicenter prospective cohort study

早期子痫前期风险预测机器学习模型的外部验证方案:一项多中心前瞻性队列研究

2026-06-110
OAAI
Abnormal Soluble fms-like Tyrosine Kinase to Placental Growth Factor Ratio during Pregnancy and Subjective Memory Impairment 3–6 Years Postpartum

妊娠期间可溶性fms样酪氨酸激酶与胎盘生长因子比值异常及产后3~6年主观记忆损伤

2026-02-200
OAAI
Ophthalmic artery Doppler and carotid intima-media thickness 3–6 years postpartum in women with and without a history of placental insufficiency

产褥期后3~6年,有和无胎盘功能不全史妇女的眼动脉多普勒和颈动脉内中膜厚度

2025-10-210
OAAI
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial

阿司匹林在24-28周停药与胎盘生物标志物轨迹:一项随机试验的事后分析

2025-09-010
PRE
Role of routine uterine artery Doppler at 18-22 and 24-28 weeks' gestation following routine first-trimester screening for pre-eclampsia

常规妊娠早期筛查先兆子痫后,在妊娠18-22和24-28周时常规子宫动脉多普勒的作用

2024-12-050
PRE
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial
2024-08-222
OAAI
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factor
2023-10-092
OA
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial Comment
2023-08-010
PRE
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia A Randomized Clinical Trial
2023-02-2124
OA